Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current challenges in HER2-positive breast cancer.
Puglisi F, Fontanella C, Amoroso V, Bianchi GV, Bisagni G, Falci C, Fontana A, Generali D, Gianni L, Grassadonia A, Moscetti L, Portarena I, Rossi E, Marchetti P. Puglisi F, et al. Among authors: falci c. Crit Rev Oncol Hematol. 2016 Feb;98:211-21. doi: 10.1016/j.critrevonc.2015.10.016. Epub 2015 Oct 31. Crit Rev Oncol Hematol. 2016. PMID: 26638862 Free article. Review.
Gemcitabine in advanced biliary tract cancers.
Pasetto LM, D'Andrea MR, Falci C, Monfardini S. Pasetto LM, et al. Among authors: falci c. Crit Rev Oncol Hematol. 2007 Mar;61(3):230-42. doi: 10.1016/j.critrevonc.2006.04.006. Epub 2006 Dec 8. Crit Rev Oncol Hematol. 2007. PMID: 17157524 Review.
Development of an oncological-multidimensional prognostic index (Onco-MPI) for mortality prediction in older cancer patients.
Brunello A, Fontana A, Zafferri V, Panza F, Fiduccia P, Basso U, Copetti M, Lonardi S, Roma A, Falci C, Monfardini S, Cella A, Pilotto A, Zagonel V. Brunello A, et al. Among authors: falci c. J Cancer Res Clin Oncol. 2016 May;142(5):1069-77. doi: 10.1007/s00432-015-2088-x. Epub 2016 Jan 12. J Cancer Res Clin Oncol. 2016. PMID: 26758276 Free PMC article.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis.
Urso L, Vernaci G, Carlet J, Lo Mele M, Fassan M, Zulato E, Faggioni G, Menichetti A, Di Liso E, Griguolo G, Falci C, Conte P, Indraccolo S, Guarneri V, Dieci MV. Urso L, et al. Among authors: falci c. Front Oncol. 2021 Mar 11;11:625636. doi: 10.3389/fonc.2021.625636. eCollection 2021. Front Oncol. 2021. PMID: 33777770 Free PMC article.
[Questionable methods in cancer therapy].
Jirillo A, Falci C. Jirillo A, et al. Among authors: falci c. Recenti Prog Med. 2005 Jul-Aug;96(7-8):344-51. Recenti Prog Med. 2005. PMID: 16209114 Review. Italian.
Quality of life in elderly cancer patients.
Pasetto LM, Falci C, Compostella A, Sinigaglia G, Rossi E, Monfardini S. Pasetto LM, et al. Among authors: falci c. Eur J Cancer. 2007 Jul;43(10):1508-13. doi: 10.1016/j.ejca.2006.11.023. Epub 2007 Feb 9. Eur J Cancer. 2007. PMID: 17292603 Review.
54 results